Both exogenous BDNF administration and an exercise-induced increase in BDNF signaling can reduce the production of toxic Aβ peptides in transgenic AD-like APP/PS1 mice, thus corroborating the idea of a direct involvement of BDNF in non-amyloidogenic APP processing [140]. This evidence concerns the gene APP and Alzheimer disease.